Intensiveret multifaktoriel intervention hos patienter med type 2-diabetes mellitus og mikroalbuminuri: Steno-2-studiet

Peter H. Gœde, Pernille Vedel Jepsen, Hans Henrik Parving, Oluf Borbye Pedersen

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review

    Abstrakt

    We carried out a randomized trial of stepwise intensive treatment or standard treatment of risk factors in patients with type 2 diabetes and microalbuminuria. Patients were allocated standard treatment (n=80) or intensive treatment (n=80). Intensive treatment was a stepwise implementation of behaviour modification, pharmacological therapy targeting hyperglycaemia, hypertension, dyslipidaemia, and microalbuminuria. The primary endpoint was development of nephropathy. Secondary endpoints were incidence or progression of diabetic retinopathy and neuropathy. Patients were followed for 3.8 years. The intensive group had significantly lower rates of progression to hephropathy (odds ratio 0.27 [95% CI 0.10-0.75]), progression of retinopathy (0.45 [0.21-0.95]), and progression of autonomic neuropathy (0.32 [0.12-0.78]). In conclusion, intensified multifactorial intervention in patients with type 2 diabetic mellitus and microalbuminuria has beneficial effects on long-term complications.

    Bidragets oversatte titelIntensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno-2 study
    OriginalsprogDansk
    Sider (fra-til)4277-4285
    Antal sider9
    TidsskriftUgeskrift for laeger
    Vol/bind161
    Udgave nummer30
    StatusUdgivet - 26 jul. 1999

    Fingeraftryk Udforsk hvilke forskningsemner 'Intensiveret multifaktoriel intervention hos patienter med type 2-diabetes mellitus og mikroalbuminuri: Steno-2-studiet' indeholder.

    Citationsformater